Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06465706 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessing the Safety and Efficacy of the LAmbre™ Plus Device

Study acronym: REDUCE-AF
StatusNot Yet Recruiting
PhaseNot applicable
Started2024-09-01
View on ClinicalTrials.gov ↗
Randomized controlled trial assessing the safety and efficacy of the LAmbre Plus LAA Closure System to rescue the risk of thromboembolism in patients with non-valvular AF.

Amendment record

Amended once since 2024-06-13. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2024-08-21
Amendment Withheld→Not Yet Recruiting Study Identification, Study Status, Sponsor/Collaborators, Oversight, Study Description, Conditions, Study Design, Arms and Interventions, Outcome Measures, Eligibility, Contacts/Locations, IPDSharing v1
2024-06-13
Original filing
Trial Details
NCT Number NCT06465706
Lead Sponsor Kansas City Heart Rhythm Research Foundation
Conditions Atrial Fibrillation
Enrollment 1,826 participants
Start Date 2024-09-01
Primary Completion 2029-10-01 (estimated)
Study Completion 2030-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-23